Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LIVELUNG - Impact of CGA on QoL, Overall Survival and the Need for Admission in Patients Diagnosed With Localized NSCLC Treated With SBRT - a National Randomized Study

NCT05919641 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT05919641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05919641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LIVELUNG - Impact of CGA on QoL, Overall Survival and the Need for Admission in Patients Diagnosed With Localized NSCLC Treated With SBRT - a National Randomized Study
Lead sponsor
Odense University Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 29, 2020
Completion date
April 1, 2025
Enrollment
130 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

comprehensive geriatric assessment, non-small cell lung cancer, stereotactic body radiotherapy